Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system). Report of two cases.
In this paper the authors describe the first use of a new liquid embolic agent (Onyx) to treat spinal cord arteriovenous malformations (AVMs). Because its properties make it more predictable to use than currently available liquid agents, the authors believe that this material has great potential in the endovascular management of both spinal cord and brain AVMs. This very promising agent merits further clinical study.
Molyneux
A J
AJ
Department of Neuroradiology, Radcliffe Infirmary, Oxford, United Kingdom. andy.molyneux@radiology.ox.ac.uk
Coley
S C
SC
D000293:Adolescent; D000792:Angiography; D001165:Arteriovenous Malformations / Q000175:diagnosis / Q000628:therapy*; D002648:Child; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004621:Embolization, Therapeutic; D006801:Humans; D008279:Magnetic Resonance Imaging; D011145:Polyvinyls / Q000627:therapeutic use*; D013116:Spinal Cord / Q000098:blood supply* / Q000000981:diagnostic imaging / Q000473:pathology
D011145:Polyvinyls; C020320:ethylene-vinyl alcohol copolymer; D004121:Dimethyl Sulfoxide